Alcon names chief medical officer

Stephen S. Lane, MD, will join Alcon as its chief medical officer and global head of franchise clinical strategy, where he will lead the integration of scientific, clinical and commercial priorities across the company’s surgical and vision care franchises, according to a press release.

Lane has specialized in cataract surgery, cornea/external diseases, anterior segment surgery, LASIK and refractive surgery in his more than 30-year career.

He also is a founding partner of Associated Eye Care and is past president of the American Society of Cataract and Refractive Surgery (ASCRS), an adjunct professor of ophthalmology at the University of Minnesota, co-chair of the ASCRS Foundation and a visiting faculty member of ORBIS International, the release said.

“His extensive experience in ophthalmic surgery, contact lens and intraocular lens development, clinical trial design and execution, and the regulatory environment complements Alcon’s medical device innovation and commercial execution strategy,” Franck Leveiller, senior vice president and global head of R&D at Alcon, said in the release.

Stephen S. Lane, MD, will join Alcon as its chief medical officer and global head of franchise clinical strategy, where he will lead the integration of scientific, clinical and commercial priorities across the company’s surgical and vision care franchises, according to a press release.

Lane has specialized in cataract surgery, cornea/external diseases, anterior segment surgery, LASIK and refractive surgery in his more than 30-year career.

He also is a founding partner of Associated Eye Care and is past president of the American Society of Cataract and Refractive Surgery (ASCRS), an adjunct professor of ophthalmology at the University of Minnesota, co-chair of the ASCRS Foundation and a visiting faculty member of ORBIS International, the release said.

“His extensive experience in ophthalmic surgery, contact lens and intraocular lens development, clinical trial design and execution, and the regulatory environment complements Alcon’s medical device innovation and commercial execution strategy,” Franck Leveiller, senior vice president and global head of R&D at Alcon, said in the release.